TTC8 Antikörper (AA 271-533) (FITC)
Kurzübersicht für TTC8 Antikörper (AA 271-533) (FITC) (ABIN8045999)
Target
Alle TTC8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 271-533
-
Verwendungszweck
- Anti-BBS8/TTC8 Antibody FITC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human BBS8/TTC8 recombinant protein (Position: E271-Q533).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- TTC8 (Tetratricopeptide Repeat Domain 8 (TTC8))
-
Andere Bezeichnung
- TTC8
-
Hintergrund
-
Background: Tetratricopeptide repeat domain 8 (TTC8) also known as Bardet-Biedl syndrome 8 is a protein that in humans is encoded by the TTC8 gene.This gene encodes a protein that has been ly linked to Bardet-Biedl syndrome. The primary features of this syndrome include retinal dystrophy, obesity, polydactyly, renal abnormalities and learning disabilities. Experimentation in non-human eukaryotes suggests that this gene is expressed in ciliated cells and that it is involved in the formation of cilia. A mutation in this gene has also been implicated in nonsyndromic retinitis pigmentosa. Alternative splicing results in multiple transcript variants.
Gene Full Name: tetratricopeptide repeat domain 8
-
Gen-ID
- 123016
-
UniProt
- Q8TAM2
-
Pathways
- Hedgehog Signalweg
Target
-